News for 'API'

Ambani bomb scare: Sachin Vaze shifted out of crime branch

Ambani bomb scare: Sachin Vaze shifted out of crime branch

Rediff.com10 Mar 2021

Maharashtra Home Minister Anil Deshmukh said on Wednesday that police officer Sachin Vaze will be removed from the Crime Branch and posted in some other department.

Dr Reddy's gets warning from US health regulator

Dr Reddy's gets warning from US health regulator

Rediff.com7 Nov 2015

Dr Reddy's gets warning from US health regulator

Why Chinese imports are likely to continue

Why Chinese imports are likely to continue

Rediff.com26 Jun 2020

Indian auto and pharma industries import several critical components and raw materials from China.

Indian pharma cos get a shot in the arm in $12-bn Australian drug market

Indian pharma cos get a shot in the arm in $12-bn Australian drug market

Rediff.com29 Apr 2022

Indian drug firms get a shot in the arm in the $12 bn Australian drug market as the Therapeutic Goods Administration (TGA), Australia agrees to accelerate the drug approval process in that country for Indian players who already have an approved plant and product from one of the stringent regulatory authorities like US, EU or Canada. From current sales of $340 mn, the Indian firms can see a significant upside in sales; felt Dinesh Dua, former chairman of the Pharmaceutical Exports Promotion Council of India (Pharmexcil), and the MD of Nectar Lifesciences. He highlighted that only 12 percent of the Australian drug market is generic, as against 80-90 per cent in the US or EU. Of this $1.5 bn generic drug market in India, Indian companies have a small share.

Drug to treat mild, moderate COVID-19 launched in India

Drug to treat mild, moderate COVID-19 launched in India

Rediff.com20 Jun 2020

FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19. Favipiravir can be used for coronavirus patients with co-morbid conditions such as diabetes and heart disease with mild to moderate COVID-19 symptoms.

Jhunjhunwala-backed Star Health's IPO scrapes through

Jhunjhunwala-backed Star Health's IPO scrapes through

Rediff.com3 Dec 2021

Star Health and Allied Insurance's Rs 7,250-crore initial public offering (IPO), the third largest this year and eighth largest ever, just about managed to make it despite a poor response from investors, garnering just 79 per cent subscription, forcing the investment bankers to prune offer for sale (OFS) component. This is the second large offering after digital payments major Paytm this year to receive a lukewarm response from investors, a sign that despite the IPO frenzy investors are discerning when it comes to pricing. As Star Health didn't meet the profitability criteria, its IPO required a mandatory 75 per cent subscription from qualified institutional buyers (QIB).

IPO frenzy continues; 2 public issues to open on Sep 1

IPO frenzy continues; 2 public issues to open on Sep 1

Rediff.com29 Aug 2021

The IPO rush will continue in September with two more companies Vijaya Diagnostic Centre and Ami Organics launching their initial share-sales on Wednesday to raise a total of Rs 2,465 crore. This comes after eight companies including Devyani International, Nuvoco Vistas Corporation and CarTrade Tech floated their initial share-sales last month to mobilise Rs 18,243 crore. So far in the current fiscal, a total of 20 companies have mopped up more than Rs 45,000 crore through IPOs. This is much higher than Rs 31,277 crore raised by 30 firms in the entire 2020-21.

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

Sputnik V vaccine to be available in India from next week: Govt

Sputnik V vaccine to be available in India from next week: Govt

Rediff.com14 May 2021

India is expecting 156 million doses of the vaccine from August to September, reports Ruchika Chitravanshi.

My Top Stock Picks for 2021

My Top Stock Picks for 2021

Rediff.com5 Jan 2021

Three stockmarket experts give their best picks for the New Year.

10 HOT careers for IT grads

10 HOT careers for IT grads

Rediff.com15 Apr 2021

Engineering graduates specialising in artificial intelligence and machine learning can earn up to 24 lakh a year, says Saran Balasundaram, founder and CEO, HanDigital, a talent consulting firm.

Anil Deshmukh accidental home minister, says Raut

Anil Deshmukh accidental home minister, says Raut

Rediff.com28 Mar 2021

Raut said the MVA government in did not have damage control machinery.

Hit by data breach? Here's how to reboot your life and control the damage

Hit by data breach? Here's how to reboot your life and control the damage

Rediff.com4 Jan 2020

By the time the security failure is discovered and fixed, the damage is already done. A CIO survey by Forcepoint and Frost & Sullivan found that 69 per cent of Indian organisations were at risk of data breach. Whenever there is data breach, there is a potential disaster waiting to happen.

Facebook says 'bug' changed 14mn users' default privacy settings to public

Facebook says 'bug' changed 14mn users' default privacy settings to public

Rediff.com8 Jun 2018

The social media giant had been under scanner lately for the growing online data-privacy concerns.

What's next for India with FASTag technology

What's next for India with FASTag technology

Rediff.com1 Apr 2022

'EV-charging is the next big opportunity after fuelling'

Jaitley to review NPAs, credit growth with bank chiefs on Tuesday

Jaitley to review NPAs, credit growth with bank chiefs on Tuesday

Rediff.com24 Sep 2018

The meeting will review annual financial performance of public sector banks, credit offtake in the economy, priority sector lending and progress made under various social sector schemes, including Atal Pension Yojana (APY) and Pradhan Mantri Jan Dhan Yojana.

Ranbaxy, US co tie up for HIV drug

Ranbaxy, US co tie up for HIV drug

Rediff.com25 Sep 2006

Ranbaxy Laboratories Ltd said on Monday it has entered into a licensing agreement with US-based Gilead Sciences Inc for manufacturing and marketing of Active Pharmaceutical Ingredient and formulations containing anti-HIV drug Tenofovir.

Indian realtors eye projects abroad

Indian realtors eye projects abroad

Rediff.com15 Oct 2007

In a notice to the stock exchanges a few days ago, DLF declared that it was going to consider international acquisitions and investments in development projects abroad. Ansals API tied up with Malaysia's UEM Group to form a 60:40 joint venture company, Ansal Api-UEM Contracts Pvt Ltd, which could bid for government projects in Malaysia, as also projects worldwide.

Param Bir Singh was hurt by Deshmukh's allegations: Sources

Param Bir Singh was hurt by Deshmukh's allegations: Sources

Rediff.com22 Mar 2021

Former Mumbai Police Commissioner Param Bir Singh, whose allegations against Maharashtra Home Minister Anil Deshmukh have created a political storm in the state, wrote a letter to the chief minister as he was hurt over remarks of Deshmukh and it was a matter relating to his 'self-respect', sources close to him have said.

FDA hikes fee for drug approvals, cuts unit inspection charge

FDA hikes fee for drug approvals, cuts unit inspection charge

Rediff.com5 Aug 2015

The fees for facility inspection of foreign companies have been reduced

Ask Anil: Your Tax Queries Answered

Ask Anil: Your Tax Queries Answered

Rediff.com13 Jul 2021

Anil Rego, CEO, Right Horizons, answers your personal income tax queries.

Banks should not feel threatened by fintech companies

Banks should not feel threatened by fintech companies

Rediff.com15 Nov 2021

'There will be partnerships between banks and fintech firms, but there will also be areas where they will be direct competitors.'

'Can I invest in NPS? I am 24'

'Can I invest in NPS? I am 24'

Rediff.com11 Mar 2021

Anil Rego, CEO, Right Horizons, answers your personal income tax queries

Glenmark to conduct trials of potential COVID-19 drug

Glenmark to conduct trials of potential COVID-19 drug

Rediff.com30 Apr 2020

As per the clinical trial protocol approved, 150 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone standard supportive care. Treatment duration is a maximum of 14 days and the total study duration will be a maximum for 28 days from randomisation.

'Nedumudi Venu made me feel like his own'

'Nedumudi Venu made me feel like his own'

Rediff.com24 Oct 2021

Poornima Indrajith, who acted with Nedumudi Venu in the daily soap Oomakkuyil for three years, shares lovely memories of the legendary actor, who passed into the ages on October 11.

A day in the life of a COVID-19 Warrior

A day in the life of a COVID-19 Warrior

Rediff.com7 Apr 2020

'My wife, who expresses her fears and anxieties every night when I return home after doing my duty at a COVID-19 containment zone, promptly wakes me up the next morning so that I can report for duty on time.'

Oil prices above $50, buoyed by US stock draw

Oil prices above $50, buoyed by US stock draw

Rediff.com22 Jun 2016

A stronger dollar makes oil more expensive because it raises the cost for imports for most of the world's countries

Pawar rules out Maha HM's exit over Param Bir's claims

Pawar rules out Maha HM's exit over Param Bir's claims

Rediff.com22 Mar 2021

Singh on Saturday claimed Deshmukh wanted police officers to collect Rs 100 crore monthly from bars and hotels.

Maha HM asked Waze to collect Rs 100 cr: Sacked CP

Maha HM asked Waze to collect Rs 100 cr: Sacked CP

Rediff.com20 Mar 2021

The former police chief also said that the Home Minister had on several occasions instructed police officers on how to handle cases and file charges.

Why Dr Reddy's expects FY19 to be stronger and richer

Why Dr Reddy's expects FY19 to be stronger and richer

Rediff.com6 Mar 2018

The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015

2 Biggest Risks for the Equity Markets

2 Biggest Risks for the Equity Markets

Rediff.com14 Jul 2021

'Q1 is going to bear the brunt of the second wave, exposing full-year GDP forecasts to downward revisions, unless phase-3 of vaccination is executed quickly.'

Govt asks states to enrol MNREGA workers under social security schemes

Govt asks states to enrol MNREGA workers under social security schemes

Rediff.com27 May 2015

The NDA government has asked states to enrol all MNREGA workers under the three newly-launched social security schemes.

Skylark Drones raises $3 mn to fuel international expansion

Skylark Drones raises $3 mn to fuel international expansion

Rediff.com6 Jul 2021

Skylark Drones, a leading drone platform company that counts Tata Steel, Ultratech Cement, Softbank Energy among its customers has secured $3 million in a pre-series A funding round. It would use the funding to strengthen its product offerings and fuel international expansion.

Land in Kalapani, Lipulekh belongs to India's border villages

Land in Kalapani, Lipulekh belongs to India's border villages

Rediff.com14 Jun 2020

Local land records also say the land at Kalapani and Lipulekh belongs to the residents of two villages on the Indian side of the border, an official recently said.

India receives 1st consignment of 1.5 lakh Sputnik V vaccine doses from Russia

India receives 1st consignment of 1.5 lakh Sputnik V vaccine doses from Russia

Rediff.com1 May 2021

Sputnik V is the third vaccine India has given the go-ahead to after 'Covishield', developed by Oxford University and AstraZeneca and 'Covaxin', the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.

SC rejects Anil Deshmukh's plea to quash CBI FIR in corruption case

SC rejects Anil Deshmukh's plea to quash CBI FIR in corruption case

Rediff.com18 Aug 2021

The Supreme Court on Wednesday dismissed a plea by former Maharashtra home minister Anil Deshmukh seeking to quash the FIR lodged against him by the Central Bureau of Investigation in a corruption case.

US regulator not happy with Sun Pharma's reply on import alert

US regulator not happy with Sun Pharma's reply on import alert

Rediff.com21 May 2014

In March, the FDA had issued an import alert, banning formulations and active pharmaceutical ingredients from the factory.

Why Modi's financial schemes are struggling

Why Modi's financial schemes are struggling

Rediff.com30 Nov 2015

The best investment schemes fail if they don't offer incentives to intermediaries to push investors.

Param Bir Singh's letter rocks LS; BJP demands probe

Param Bir Singh's letter rocks LS; BJP demands probe

Rediff.com22 Mar 2021

"It is a serious matter. The home minister should resign, the Maharashtra government should resign and there should be a CBI inquiry into the whole issue'